A kidney disorder that alters mineral balance
Gitelman syndrome is a recessive genetic disorder linked to the SLC12A3 gene. It affects the renal tubules and is characterized in particular by low blood potassium, low blood magnesium, metabolic alkalosis and low urinary calcium excretion.
Pregnancy can intensify these imbalances. The question being studied is therefore not routine supplementation during pregnancy, but the management of a specific kidney disorder.
What the researchers gathered
The review searched four bibliographic databases for publications through December 31, 2025. It includes 56 studies describing 96 pregnancies in 81 women across 19 countries. Two reviewers independently selected publications, extracted data and assessed their quality.
The results were analyzed descriptively. This was not a trial comparing treatments, and data on every complication were not available for all pregnancies.
Reported complications, not an established individual risk
Among pregnancies with available outcome data, the authors report gestational diabetes in 11.5% of cases and insufficient amniotic fluid in 9.4%. Preterm birth was reported in 16.7% of cases and fetal or neonatal death in 4.2%. These proportions describe published cases, not necessarily all pregnancies involving this syndrome.
A diagnosis established before conception was associated with less gestational diabetes and fewer fetal or neonatal deaths. However, the authors stress that these comparisons are exploratory: they do not demonstrate that early diagnosis alone explains the observed differences.
Individualized monitoring, without a proven protocol
Oral potassium and magnesium were the main treatments reported. Potassium-sparing diuretics were also used in 16 pregnancies. No malformations were reported with these exposures, but this small number cannot establish their safety.
The authors suggest that preconception support, multidisciplinary care and close electrolyte monitoring could be useful. However, this review provides neither a validated protocol nor a dose that can be applied to another patient.
Limitations to keep in mind
Data drawn from published cases, subject to publication bias and heterogeneous. Results are not available for all pregnancies. Comparisons are descriptive and exploratory. Only the supplied PubMed abstract was consulted, not the full text. Funding and conflicts of interest could not be verified.
What we can take away
This review documents the challenges of pregnancies involving Gitelman syndrome, but does not demonstrate which strategy reduces complications. It does not justify routine supplementation in other pregnancies.
Sources and provenance
- Gitelman syndrome complicated by pregnancy: clinical management and maternal-fetal outcomes - a systematic review.
Source date: 2026-11-18.
Journal Article, Systematic Review, Review · Résumé PubMed uniquement, texte intégral non consulté


